• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Replacement of recipient hematopoietic cells with donor cells may be a major factor in HIV remission after allo-HSCT

byCaitlyn HuiandDeepti Shroff Karhade
October 19, 2018
in Chronic Disease, Infectious Disease, Preclinical, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Allo-HSCT treatment resulted in significant prolonged reduction in HIV-1 viral reservoirs.

2. Mouse models showed adoptive transfer of peripheral CD4+ T cells to immunosuppressed mice resulted in no rebound of the viral load.

Evidence Rating Level: 2 (Good)

Study Rundown: While combination antiretroviral therapy (cART) has been highly successful at reducing morbidity and mortality associated with HIV, it has not been proven to completely eliminate the virus, as a latent HIV-1 viral reservoir often remains. One therapy, allogeneic hematopoietic stem cell transplant (allo-HSCT), has been proposed as a potential treatment poised to eliminate the HIV-1 virus. The authors of this study aimed to investigate the mechanism of HIV-1 eradication associated with allo-HSCT. They observed that the replacement of recipient hematopoietic cells with donor cells may be a major factor in HIV remission after this treatment. The main limitation of this study was its small sample size.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies

RELATED REPORTS

Second-line TAF-based ART improves viral suppression in pediatric HIV

Alcohol use disorder may be associated with human immunodeficiency virus

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

In-Depth [nested case series]: The authors of this study conducted a nested case series within the IciStem observational cohort—the largest observational cohort for the study of HIV reservoir dynamics. The goal of the study was to further elucidate the mechanism of HIV-1 eradication related to allo-HSCT. Study outcomes included HIV DNA analysis, HIV RNA analysis, and quantitative viral outgrowth assay. Furthermore, the authors used a humanized mouse model for in vivo detection of the replication-competent blood cell reservoir. Six participants from the cohort met study criteria, and of these participants, five had a full donor chimera in T cells within the first year after transplant and undetectable proviral HIV DNA in blood and tissue. Furthermore, HIV was undetectable in CSF and cells from bone marrow, lymph node, and ileal biopsy specimens.

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: HIVstem cells
Previous Post

ICU admissions among Medicare beneficiaries on a decade-long downward trend

Next Post

No benefit of myo-inositol on type 1 retinopathy of prematurity in preterm Infants

RelatedReports

Government-funded initiatives provide important supports to low-income HIV patients
Infectious Disease

Second-line TAF-based ART improves viral suppression in pediatric HIV

June 4, 2025
Few high school students, young adults get HIV testing
Chronic Disease

Alcohol use disorder may be associated with human immunodeficiency virus

May 3, 2025
#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons
StudyGraphics

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

December 11, 2024
Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men
Infectious Disease

Kidneys from donors with HIV have good safety outcomes in persons with HIV

November 22, 2024
Next Post
Infant room-sharing associated with less nighttime sleep and unsafe sleep practices

No benefit of myo-inositol on type 1 retinopathy of prematurity in preterm Infants

Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure

2 Minute Medicine Rewind October 23, 2018

Gene therapy targets Duchenne muscular dystrophy in new trial [PreClinical]

Gene therapy targets Duchenne muscular dystrophy in new trial [PreClinical]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind June 23, 2025
  • Reductions in pain catastrophizing are associated with improvements in emotional functioning
  • Repeated medial branch blocks do not improve pain outcomes for thermal radiofrequency ablation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.